acetazolamide has been researched along with Central Retinal Edema, Cystoid in 78 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Addition of oral acetazolamide to IVB in eyes with macular edema secondary to RVO may not result in additional short-term benefits regarding functional and anatomical outcomes." | 9.69 | Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion. ( Abtahi, SH; Ansari, I; Barkhordari, S; Karimi, S; Nafisi, H; Nikkhah, H; Nouri, H; Samnejad, S, 2023) |
| " However, the present study seems to suggest that acetazolamide could be effective in reducing fluorescein-angiographic findings and improving perimetric data in diabetics with macular edema, even though the mechanism of action remains obscure." | 9.09 | Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. ( Forte, R; Gargiulo, P; Giusti, C; Vingolo, EM, 2001) |
| "The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa." | 9.08 | The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. ( Engler, C; Larsen, M; Li, B; Lund-Andersen, H; Moldow, B; Rosenberg, T; Sander, B, 1998) |
| "Dorzolamide provided improvement in cases of macular edema on fluorescein angiograms and subjective improvement of visual function in some patients with retinitis pigmentosa with cystoid macular edema." | 9.08 | Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. ( Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S, 1997) |
| "A 4-week course of acetazolamide therapy results in a statistically significant but small decrease in cystoid macular edema in patients with chronic uveitis, and does not improve visual acuity." | 9.08 | A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. ( Chew, EY; Csaky, KG; Nussenblatt, RB; Perry, CH; Podgor, MJ; Whitcup, SM, 1996) |
| "Twelve patients with retinitis pigmentosa and chronic macular edema were prospectively treated for 2-week periods with acetazolamide or a placebo in a masked, crossover study." | 9.06 | Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. ( Fiscella, RG; Fishman, GA; Gilbert, LD; Jampol, LM; Kimura, AE, 1989) |
| " Pseudophakic cystoid macular edema (PCME) was diagnosed, and treatment with oral acetazolamide was tried without success." | 8.31 | Intravitreal acetazolamide implant for pseudophakic cystoid macular edema. ( da Silva Cunha, A; da Silva, PHR; de Azevedo Bastos, TM; Fernandes, C; Fialho, SL; Jorge, R; Messias, A; Scott, IU; Villela, IF, 2023) |
| "There is a significant benefit to vision and central macular subfield thickness after acetazolamide treatment in patients with inflammatory macular edema." | 7.91 | RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE. ( Lee, C; Leveque, TK; Nguyen, MH; Odell, N; Pakzad-Vaezi, K; Pepple, KL; Van Gelder, RN; Williamson, K, 2019) |
| "Hydroxychloroquine (HCQ) retinopathy can accompany other retinal complications such as cystoid macular edema (CME), which leads to central visual loss." | 7.85 | The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report. ( Ahn, SJ; Hong, EH; Lee, BR; Lim, HW, 2017) |
| "We continued fingolimod and added oral acetazolamide, which led to recovery of visual acuity and regression of macular edema." | 7.81 | Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations. ( Aktas, O; Finis, D; Geerling, G; Guthoff, R; Harmel, J; Hartung, HP; Ringelstein, M; Schröder, K, 2015) |
| "To demonstrate the presence of a rebound effect with the use of acetazolamide for the treatment of cystoid macular edema (CME) in patients with retinitis pigmentosa (RP)." | 7.74 | Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. ( Apushkin, MA; Fishman, GA; Grover, S; Janowicz, MJ, 2007) |
| "To analyze the effectiveness of acetazolamide associated with topical nonsteroidal anti-inflammatory drugs (NSAIDs) and/or steroids in the treatment of postsurgical macular edema (ME)." | 7.73 | [Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema]. ( Catier, A; Gaudric, A; Massin, P; Tadayoni, R, 2005) |
| "We report the case of a patient with pseudophakic cystoid macular edema whose visual acuity improved promptly with oral administration of 500 mg of acetazolamide extended-release capsules BID for two weeks." | 7.68 | A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. ( Ernest, JT; Fekrat, S; Tripathi, BJ; Tripathi, RC, 1991) |
| "The results show that acetazolamide is a basically effective agent against cystoid macular edema and that a therapeutical trial is justified based on the treatment criteria of this study." | 7.68 | [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)]. ( Pauleikhoff, D; Schilling, H; Schrenk, M; Wessing, A, 1993) |
| "The authors studied the therapeutic effect of acetazolamide on a patient with autosomal dominant retinitis pigmentosa complicated by retinal edema." | 7.68 | Long-term effect of acetazolamide in a patient with retinitis pigmentosa. ( Bird, AC; Chen, JC; Fitzke, FW, 1990) |
| "In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 7.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
| "Addition of oral acetazolamide to IVB in eyes with macular edema secondary to RVO may not result in additional short-term benefits regarding functional and anatomical outcomes." | 5.69 | Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion. ( Abtahi, SH; Ansari, I; Barkhordari, S; Karimi, S; Nafisi, H; Nikkhah, H; Nouri, H; Samnejad, S, 2023) |
| "Acetazolamide is a treatment option for MME associated with ON but without an impact on the visual function." | 5.48 | Acetazolamide Reduces Retinal Inner Nuclear Layer Thickness in Microcystic Macular Edema Secondary to Optic Neuropathy. ( Abegg, M; Borruat, FX; Dysli, M; Voide, N, 2018) |
| "The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops." | 5.48 | Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification. ( Georgakopoulos, CD; Makri, OE; Pallikari, A; Plotas, P; Tsapardoni, F; Tsekouras, IK, 2018) |
| " However, the present study seems to suggest that acetazolamide could be effective in reducing fluorescein-angiographic findings and improving perimetric data in diabetics with macular edema, even though the mechanism of action remains obscure." | 5.09 | Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. ( Forte, R; Gargiulo, P; Giusti, C; Vingolo, EM, 2001) |
| "The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa." | 5.08 | The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. ( Engler, C; Larsen, M; Li, B; Lund-Andersen, H; Moldow, B; Rosenberg, T; Sander, B, 1998) |
| "A 4-week course of acetazolamide therapy results in a statistically significant but small decrease in cystoid macular edema in patients with chronic uveitis, and does not improve visual acuity." | 5.08 | A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis. ( Chew, EY; Csaky, KG; Nussenblatt, RB; Perry, CH; Podgor, MJ; Whitcup, SM, 1996) |
| "Dorzolamide provided improvement in cases of macular edema on fluorescein angiograms and subjective improvement of visual function in some patients with retinitis pigmentosa with cystoid macular edema." | 5.08 | Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. ( Adelman, AE; Fiscella, RG; Fishman, GA; Grover, S, 1997) |
| "Twelve patients with retinitis pigmentosa and chronic macular edema were prospectively treated for 2-week periods with acetazolamide or a placebo in a masked, crossover study." | 5.06 | Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. ( Fiscella, RG; Fishman, GA; Gilbert, LD; Jampol, LM; Kimura, AE, 1989) |
| " Pseudophakic cystoid macular edema (PCME) was diagnosed, and treatment with oral acetazolamide was tried without success." | 4.31 | Intravitreal acetazolamide implant for pseudophakic cystoid macular edema. ( da Silva Cunha, A; da Silva, PHR; de Azevedo Bastos, TM; Fernandes, C; Fialho, SL; Jorge, R; Messias, A; Scott, IU; Villela, IF, 2023) |
| "There is a significant benefit to vision and central macular subfield thickness after acetazolamide treatment in patients with inflammatory macular edema." | 3.91 | RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE. ( Lee, C; Leveque, TK; Nguyen, MH; Odell, N; Pakzad-Vaezi, K; Pepple, KL; Van Gelder, RN; Williamson, K, 2019) |
| "Hydroxychloroquine (HCQ) retinopathy can accompany other retinal complications such as cystoid macular edema (CME), which leads to central visual loss." | 3.85 | The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report. ( Ahn, SJ; Hong, EH; Lee, BR; Lim, HW, 2017) |
| "Gyrate atrophy of the choroid and retina (GACR) is a rare chorioretinal dystrophy characterized by a deficiency of the enzyme ornithine aminotransferase, inherited in an autosomal recessive pattern." | 3.85 | Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy. ( Alessi, S; Cillino, G; Cillino, S; Iggui, A; Mazza, M; Piozzi, E; Santambrogio, S, 2017) |
| "We continued fingolimod and added oral acetazolamide, which led to recovery of visual acuity and regression of macular edema." | 3.81 | Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations. ( Aktas, O; Finis, D; Geerling, G; Guthoff, R; Harmel, J; Hartung, HP; Ringelstein, M; Schröder, K, 2015) |
| "The purpose of this paper was to describe a patient with pericentral retinitis pigmentosa (RP) and cystoid macular edema (CME) refractory to oral acetazolamide alone who was successfully treated with adjunctive pegaptanib sodium." | 3.75 | Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. ( Iaculli, C; Noci, ND; Prascina, F; Querques, G, 2009) |
| "To demonstrate the presence of a rebound effect with the use of acetazolamide for the treatment of cystoid macular edema (CME) in patients with retinitis pigmentosa (RP)." | 3.74 | Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. ( Apushkin, MA; Fishman, GA; Grover, S; Janowicz, MJ, 2007) |
| "To identify cystoid macular edema (CME) in patients with retinitis pigmentosa (RP) using optical coherence tomography (OCT) and to evaluate response to acetazolamide by serial OCT." | 3.73 | Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa. ( Chung, H; Hwang, JU; Kim, JG; Yoon, YH, 2006) |
| "To analyze the effectiveness of acetazolamide associated with topical nonsteroidal anti-inflammatory drugs (NSAIDs) and/or steroids in the treatment of postsurgical macular edema (ME)." | 3.73 | [Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema]. ( Catier, A; Gaudric, A; Massin, P; Tadayoni, R, 2005) |
| "The lipophilic carbonic anhydrase (CA) inhibitor acetazolamide has been shown to enhance subretinal fluid resorption, reduce subretinal pH, and can improve cystoid macular edema, but its clinical use is limited by systemic side effects." | 3.70 | Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume. ( Dmitriev, AV; Govardovskii, VI; Wolfensberger, TJ, 1999) |
| "After 7 months of treatment for bilateral panuveitis with topical steroid and tropicamide, the patient developed a thin, transparent membrane arising on the lens surface in the right eye." | 3.70 | True exfoliation of the lens capsule following uveitis. ( Miyagawa, A; Yamamoto, N, 2000) |
| "The results show that acetazolamide is a basically effective agent against cystoid macular edema and that a therapeutical trial is justified based on the treatment criteria of this study." | 3.68 | [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)]. ( Pauleikhoff, D; Schilling, H; Schrenk, M; Wessing, A, 1993) |
| "We report the case of a patient with pseudophakic cystoid macular edema whose visual acuity improved promptly with oral administration of 500 mg of acetazolamide extended-release capsules BID for two weeks." | 3.68 | A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy. ( Ernest, JT; Fekrat, S; Tripathi, BJ; Tripathi, RC, 1991) |
| "The authors studied the therapeutic effect of acetazolamide on a patient with autosomal dominant retinitis pigmentosa complicated by retinal edema." | 3.68 | Long-term effect of acetazolamide in a patient with retinitis pigmentosa. ( Bird, AC; Chen, JC; Fitzke, FW, 1990) |
| "In a prospective study, 41 patients with documented chronic macular edema of various causes were entered into a therapeutic trial of acetazolamide sodium, a carbonic anhydrase inhibitor." | 3.67 | Treatment of chronic macular edema with acetazolamide. ( Bird, AC; Cox, SN; Hay, E, 1988) |
| "Initial angiographic cystoid macular edema was comparable and significantly improved after therapy in the two treatment groups." | 2.67 | [Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema]. ( Guex-Crosier, Y; Herbort, CP; Othenin-Girard, P, 1992) |
| "Medical treatment of cystoid macular edema (CME) with carbonic anhydrase inhibitors has been known for over a decade." | 2.40 | The role of carbonic anhydrase inhibitors in the management of macular edema. ( Wolfensberger, TJ, 1999) |
| "Acetazolamide (ACZ), which is a CAI, is an active substance that has been used off-label for many years in the treatment of macular edema due to diabetes and many other diseases." | 1.91 | Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle. ( Akyol, M; Alçığır, ME; Arslan, A; Bakici, C; Batur, B; Ekim, O; Erdal, E; Salih, B; Uğurlu, N; Yaman, ME, 2023) |
| "Acetazolamide is a treatment option for MME associated with ON but without an impact on the visual function." | 1.48 | Acetazolamide Reduces Retinal Inner Nuclear Layer Thickness in Microcystic Macular Edema Secondary to Optic Neuropathy. ( Abegg, M; Borruat, FX; Dysli, M; Voide, N, 2018) |
| "The rechallenge-induced cystoid macular edema once again resolved after cessation of latanoprost and retreatment with nepafenac eye drops." | 1.48 | Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification. ( Georgakopoulos, CD; Makri, OE; Pallikari, A; Plotas, P; Tsapardoni, F; Tsekouras, IK, 2018) |
| "Acetazolamide treatment resulted in oedema resolution and improvement in visual function, and can be considered a therapeutic option for other patients with Bietti dystrophy who develop cystoid macular oedema." | 1.40 | Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy. ( Broadhead, GK; Chang, AA, 2014) |
| "A 75-year-old man without Fuchs dystrophy underwent cataract extraction on his right eye in 2007, and 5 years later, Descemet membrane endothelial keratoplasty was performed for pseudophakic edema in the same eye at another center." | 1.40 | Progressive corneal clearance after a DMEK graft partially folded over on itself in a non-fuchs pseudophakic eye. ( Elies, D; Gris, O; Güell, JL; Ponce de Los Ríos, CD, 2014) |
| "In one eye, the cystoid macular edema was worsened by formation of a dense juxtafoveal epiretinal membrane." | 1.30 | Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. ( Cunningham, ET; Jones, MR; Schwartz, D; Silverstein, BE; Smith, JH; Sykes, SO, 1998) |
| "The primary lesion in dominant cystoid macular dystrophy remains obscure." | 1.29 | Acetazolamide in dominant cystoid macular dystrophy. A pilot study. ( Aandekerk, AL; Cruysberg, JR; Kremer, H; Pinckers, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.56) | 18.7374 |
| 1990's | 21 (26.92) | 18.2507 |
| 2000's | 20 (25.64) | 29.6817 |
| 2010's | 30 (38.46) | 24.3611 |
| 2020's | 5 (6.41) | 2.80 |
| Authors | Studies |
|---|---|
| Karimi, S | 1 |
| Nikkhah, H | 1 |
| Nafisi, H | 1 |
| Nouri, H | 1 |
| Ansari, I | 1 |
| Barkhordari, S | 1 |
| Samnejad, S | 1 |
| Abtahi, SH | 1 |
| Jorge, R | 1 |
| Villela, IF | 1 |
| Fernandes, C | 1 |
| de Azevedo Bastos, TM | 1 |
| Scott, IU | 1 |
| da Silva Cunha, A | 1 |
| Fialho, SL | 1 |
| da Silva, PHR | 1 |
| Messias, A | 1 |
| Erdal, E | 1 |
| Bakici, C | 1 |
| Arslan, A | 1 |
| Batur, B | 1 |
| Yaman, ME | 1 |
| Alçığır, ME | 1 |
| Akyol, M | 1 |
| Ekim, O | 1 |
| Salih, B | 1 |
| Uğurlu, N | 1 |
| Chatzistergiou, V | 1 |
| Papasavvas, I | 1 |
| Escher, P | 1 |
| Durig, J | 1 |
| Vaudaux, J | 1 |
| Pournaras, JA | 1 |
| Ambresin, A | 1 |
| Erokhina, M | 1 |
| Szurman, P | 1 |
| Dimopoulos, S | 1 |
| Januschowski, K | 1 |
| Seuthe, AM | 1 |
| Hong, EH | 1 |
| Ahn, SJ | 1 |
| Lim, HW | 1 |
| Lee, BR | 1 |
| Piozzi, E | 1 |
| Alessi, S | 1 |
| Santambrogio, S | 1 |
| Cillino, G | 1 |
| Mazza, M | 1 |
| Iggui, A | 1 |
| Cillino, S | 1 |
| Huang, Q | 1 |
| Chen, R | 1 |
| Lin, X | 1 |
| Xiang, Z | 1 |
| Pepple, KL | 1 |
| Nguyen, MH | 1 |
| Pakzad-Vaezi, K | 1 |
| Williamson, K | 1 |
| Odell, N | 1 |
| Lee, C | 1 |
| Leveque, TK | 1 |
| Van Gelder, RN | 1 |
| Fakhoury, O | 1 |
| Conrath, J | 1 |
| Donnadieu, B | 1 |
| Warrak, R | 1 |
| Matonti, F | 1 |
| Borruat, FX | 1 |
| Dysli, M | 1 |
| Voide, N | 1 |
| Abegg, M | 1 |
| Strong, SA | 1 |
| Hirji, N | 1 |
| Quartilho, A | 1 |
| Kalitzeos, A | 1 |
| Michaelides, M | 2 |
| Makri, OE | 1 |
| Tsekouras, IK | 1 |
| Plotas, P | 1 |
| Tsapardoni, F | 1 |
| Pallikari, A | 1 |
| Georgakopoulos, CD | 1 |
| Jin Choi, H | 1 |
| Cordovez, JA | 1 |
| Traboulsi, EI | 1 |
| Capasso, JE | 1 |
| Sadagopan, KA | 1 |
| Ganesh, A | 2 |
| Rychwalski, PJ | 1 |
| Neely, KA | 1 |
| Brodie, SE | 1 |
| Levin, AV | 2 |
| Broadhead, GK | 1 |
| Chang, AA | 1 |
| Ponce de Los Ríos, CD | 1 |
| Gris, O | 1 |
| Elies, D | 1 |
| Güell, JL | 1 |
| Gelman, SK | 1 |
| Gorin, MB | 2 |
| Liew, G | 1 |
| Moore, AT | 1 |
| Webster, AR | 1 |
| Liu, X | 1 |
| Zhang, M | 1 |
| Schröder, K | 1 |
| Finis, D | 1 |
| Harmel, J | 1 |
| Ringelstein, M | 1 |
| Hartung, HP | 1 |
| Geerling, G | 1 |
| Aktas, O | 1 |
| Guthoff, R | 1 |
| Daien, V | 1 |
| Papinaud, L | 1 |
| Domerg, C | 1 |
| Lacombe, S | 1 |
| Daures, JP | 1 |
| Villain, M | 1 |
| Lingao, MD | 1 |
| Karthikeyan, AS | 1 |
| Al Zuhaibi, S | 1 |
| Al-Hosni, A | 1 |
| Al Khayat, A | 1 |
| Capasso, J | 1 |
| Trumler, AA | 1 |
| Stroh, E | 1 |
| Al Shekaili, H | 1 |
| Cater, JR | 1 |
| Dhrami-Gavazi, E | 1 |
| Goldberg, NR | 1 |
| Freund, KB | 1 |
| Vora, RA | 1 |
| Schaal, Y | 1 |
| Hondur, AM | 1 |
| Tezel, TH | 1 |
| Verbakel, SK | 1 |
| van de Ven, JP | 1 |
| Le Blanc, LM | 1 |
| Groenewoud, JM | 1 |
| de Jong, EK | 1 |
| Klevering, BJ | 1 |
| Hoyng, CB | 1 |
| Andreuzzi, P | 1 |
| Fishman, GA | 5 |
| Anderson, RJ | 1 |
| Dinç, UA | 1 |
| Yenerel, NM | 1 |
| Görgün, E | 1 |
| Yetik, H | 1 |
| Kokame, GT | 1 |
| Lim, JI | 1 |
| Abouzeid, H | 1 |
| Wolfensberger, TJ | 3 |
| Schorderet, DF | 1 |
| Munier, FL | 1 |
| Caramoy, A | 1 |
| Fauser, S | 1 |
| Kirchhof, B | 1 |
| Liakopoulos, S | 1 |
| Artunay, O | 1 |
| Yuzbasioglu, E | 1 |
| Rasier, R | 1 |
| Sengul, A | 1 |
| Bahcecioglu, H | 1 |
| Cohen, SM | 1 |
| Reichel, E | 1 |
| Arroyo, JG | 1 |
| Lujan, BJ | 1 |
| Thobani, A | 1 |
| Buyukyildiz, HZ | 1 |
| Gulkilik, G | 1 |
| Kumcuoglu, YZ | 1 |
| Ossewaarde-van Norel, A | 1 |
| Rothova, A | 2 |
| Ossewaarde-van Norel, J | 1 |
| Berg, EM | 1 |
| Sijssens, KM | 1 |
| Martínez-Castillo, S | 1 |
| Gallego-Pinazo, R | 2 |
| Díaz-Llopis, M | 2 |
| Meyer, KM | 1 |
| Klink, T | 1 |
| Ugurel, S | 1 |
| Bröcker, EB | 1 |
| Martínez Castillo, S | 1 |
| Dolz-Marco, R | 1 |
| Lleó-Pérez, A | 1 |
| Giusti, C | 1 |
| Forte, R | 1 |
| Vingolo, EM | 1 |
| Gargiulo, P | 1 |
| Lashay, AR | 1 |
| Rahimi, A | 1 |
| Chams, H | 1 |
| Davatchi, F | 1 |
| Shahram, F | 1 |
| Hatmi, ZN | 1 |
| Khalkhali, H | 1 |
| Beigi, B | 1 |
| Hori, K | 1 |
| Ishida, S | 1 |
| Inoue, M | 1 |
| Shinoda, K | 1 |
| Kawashima, S | 1 |
| Kitamura, S | 1 |
| Oguchi, Y | 1 |
| Lois, N | 1 |
| White, M | 1 |
| Thurau, SR | 1 |
| Kitano, S | 1 |
| Curković, T | 1 |
| Vukojević, N | 1 |
| Bućan, K | 1 |
| Catier, A | 1 |
| Tadayoni, R | 1 |
| Massin, P | 1 |
| Gaudric, A | 1 |
| Chung, H | 1 |
| Hwang, JU | 1 |
| Kim, JG | 1 |
| Yoon, YH | 1 |
| Ghajarnia, M | 1 |
| Sivaprasad, S | 1 |
| Ikeji, F | 1 |
| Xing, W | 1 |
| Lightman, S | 1 |
| Apushkin, MA | 1 |
| Grover, S | 2 |
| Janowicz, MJ | 1 |
| Querques, G | 1 |
| Prascina, F | 1 |
| Iaculli, C | 1 |
| Noci, ND | 1 |
| Miyake, Y | 1 |
| Awaya, S | 1 |
| Takahashi, H | 1 |
| Tomita, N | 1 |
| Hirano, K | 1 |
| Pinckers, A | 1 |
| Cruysberg, JR | 1 |
| Kremer, H | 1 |
| Aandekerk, AL | 1 |
| Schilling, H | 1 |
| Pauleikhoff, D | 1 |
| Schrenk, M | 1 |
| Wessing, A | 1 |
| Whitcup, SM | 1 |
| Csaky, KG | 1 |
| Podgor, MJ | 1 |
| Chew, EY | 1 |
| Perry, CH | 1 |
| Nussenblatt, RB | 1 |
| Horgan, SE | 1 |
| Fraser, SG | 1 |
| Ferrante, PF | 1 |
| Spencer, A | 1 |
| Beaconsfield, M | 1 |
| Flach, A | 1 |
| Rho, D | 1 |
| Fiscella, RG | 2 |
| Adelman, AE | 1 |
| Silverstein, BE | 1 |
| Smith, JH | 1 |
| Sykes, SO | 1 |
| Jones, MR | 1 |
| Schwartz, D | 1 |
| Cunningham, ET | 1 |
| Moldow, B | 1 |
| Sander, B | 1 |
| Larsen, M | 1 |
| Engler, C | 1 |
| Li, B | 1 |
| Rosenberg, T | 1 |
| Lund-Andersen, H | 1 |
| Hansen, LL | 1 |
| Flach, AJ | 1 |
| Dmitriev, AV | 1 |
| Govardovskii, VI | 1 |
| Zierhut, M | 1 |
| Thiel, HJ | 1 |
| Schlote, T | 1 |
| Yamamoto, N | 1 |
| Miyagawa, A | 1 |
| Krott, R | 1 |
| Heller, R | 1 |
| Aisenbrey, S | 1 |
| Bartz-Schmidt, KU | 1 |
| Stanga, PE | 1 |
| Downes, SM | 1 |
| Ahuja, RM | 1 |
| Chong, NH | 1 |
| Antcliff, R | 1 |
| Reck, AC | 1 |
| Bird, AC | 4 |
| Weene, LE | 1 |
| Guex-Crosier, Y | 1 |
| Othenin-Girard, P | 1 |
| Herbort, CP | 1 |
| Steinmetz, RL | 1 |
| Fitzke, FW | 2 |
| Tripathi, RC | 1 |
| Fekrat, S | 1 |
| Tripathi, BJ | 1 |
| Ernest, JT | 1 |
| Gelişken, O | 1 |
| Gelişken, F | 1 |
| Ozçetin, H | 1 |
| Chen, JC | 1 |
| Gilbert, LD | 1 |
| Kimura, AE | 1 |
| Jampol, LM | 1 |
| Cox, SN | 1 |
| Hay, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Intravitreal Ranibizumab (Lucentis®) Injection in the Treatment of Non-leaking Macular Cysts in Patients With Retinal Dystrophy.[NCT03763227] | Phase 2 | 13 participants (Actual) | Interventional | 2015-07-24 | Completed | ||
| [NCT00000115] | Phase 2 | 0 participants | Interventional | 1990-12-31 | Completed | ||
| The Effect of Topical Corticosteroids and Topical NSAIDs Perioperatively on IL6 Levels in Aqueous Humor and on Incidence of PCME in Patients With NPDR[NCT04940338] | Phase 4 | 90 participants (Actual) | Interventional | 2021-05-01 | Completed | ||
| Changes of Macular Vasculature After Uncomplicated Phacoemulsification Surgery Using Optical Coherence Tomography Angiography[NCT04594603] | 30 participants (Anticipated) | Observational [Patient Registry] | 2021-04-13 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for acetazolamide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Carbonic Anhydrase Inhibitors; Clinica | 2017 |
Clinical review: Update on treatment of inflammatory macular edema.
Topics: Acetazolamide; Adrenal Cortex Hormones; Algorithms; Anti-Inflammatory Agents; Drug Implants; Humans; | 2011 |
[Medications for diabetic macular edema].
Topics: Acetazolamide; Diabetic Retinopathy; Diagnostic Techniques, Ophthalmological; Humans; Indoles; Injec | 2005 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.
Topics: Acetazolamide; Administration, Oral; Aged; Aged, 80 and over; Cataract Extraction; Chronic Disease; | 1998 |
The role of carbonic anhydrase inhibitors in the management of macular edema.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane Permeability; Choro | 1999 |
11 trials available for acetazolamide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Acetazolamide and bevacizumab combination therapy versus bevacizumab monotherapy in macular edema secondary to retinal vein occlusion.
Topics: Acetazolamide; Angiogenesis Inhibitors; Bevacizumab; Humans; Intravitreal Injections; Macula Lutea; | 2023 |
Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa.
Topics: Acetazolamide; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Carbonic Anhydrase | 2009 |
Subfoveal serous retinal detachment in patients with uveitic macular edema.
Topics: Acetazolamide; Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Female; Foll | 2011 |
Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Melli | 2001 |
Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet's disease.
Topics: Acetazolamide; Adolescent; Adult; Behcet Syndrome; Carbonic Anhydrase Inhibitors; Cross-Over Studies | 2003 |
Treatment of pseudophakic cystoid macular oedema.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Anti-Inflamm | 2005 |
A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Chronic Disease; Cross-Over S | 1996 |
Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Carbonic Anhy | 1997 |
The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Topics: Acetazolamide; Adult; Biological Transport, Active; Blood-Retinal Barrier; Carbonic Anhydrase Inhibi | 1998 |
[Differential treatment of postoperative and uveitis-induced inflammatory cystoid macular edema].
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Diclofenac; Female; Humans; Injections; Lenses, Intra | 1992 |
Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa.
Topics: Acetazolamide; Adult; Aged; Cross-Sectional Studies; Dose-Response Relationship, Drug; Double-Blind | 1989 |
62 other studies available for acetazolamide and Central Retinal Edema, Cystoid
| Article | Year |
|---|---|
Intravitreal acetazolamide implant for pseudophakic cystoid macular edema.
Topics: Acetazolamide; Cataract; Cataract Extraction; Electroretinography; Female; Humans; Intravitreal Inje | 2023 |
Ocular pharmacokinetics and toxicity of nanoparticular acetazolamide: In vivo distribution and safety of PHBV-ACZ nanoparticle.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Diabetic Retinopathy; Glaucoma; Humans; Intraocular Pr | 2023 |
Optical Coherence Tomography Analysis of Cystoid Macular Edema in Retinal Dystrophy Treated with Oral Acetazolamide: Two Cases.
Topics: Acetazolamide; Fluorescein Angiography; Humans; Macular Edema; Retinal Dystrophies; Tomography, Opti | 2020 |
Postoperative cystoid macular oedema after non-penetrating glaucoma surgery.
Topics: Acetazolamide; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Carbonic Anhydrase | 2021 |
The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
Topics: Acetazolamide; Administration, Oral; Antirheumatic Agents; Carbonic Anhydrase Inhibitors; Dose-Respo | 2017 |
Carbonic Anhydrase Inhibitor with Topical NSAID Therapy to Manage Cystoid Macular Edema in a Case of Gyrate Atrophy.
Topics: Acetazolamide; Administration, Ophthalmic; Administration, Oral; Adolescent; Anti-Inflammatory Agent | 2017 |
RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE.
Topics: Acetazolamide; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; | 2019 |
Treatment of cystoid macular edema in homozygous twins with glutathione synthetase deficiency and retinal dystrophy.
Topics: Acetazolamide; Administration, Oral; Amino Acid Metabolism, Inborn Errors; Child; Combined Modality | 2018 |
Acetazolamide Reduces Retinal Inner Nuclear Layer Thickness in Microcystic Macular Edema Secondary to Optic Neuropathy.
Topics: Acetazolamide; Adult; Aged; Diuretics; Female; Humans; Macular Edema; Male; Middle Aged; Optic Nerve | 2018 |
Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
Topics: Acetazolamide; Adolescent; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema | 2019 |
Cystoid Macular Edema Due to Accidental Latanoprost Overdose After Uncomplicated Phacoemulsification.
Topics: Acetazolamide; Aged; Antihypertensive Agents; Benzeneacetamides; Drug Overdose; Humans; Latanoprost; | 2018 |
Corneal edema and cystoid macular edema by nuclear fragments after uneventful phacoemulsification.
Topics: Acetazolamide; Aged; Anterior Eye Segment; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-S | 2013 |
Retinal Dystrophy with Intraretinal Cystoid Spaces Associated with Mutations in the Crumbs Homologue (CRB1) Gene.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Eye Proteins; Fem | 2015 |
Acetazolamide for cystoid macular oedema in Bietti crystalline retinal dystrophy.
Topics: Acetazolamide; Administration, Oral; Adult; Corneal Dystrophies, Hereditary; Diuretics; Humans; Macu | 2014 |
Progressive corneal clearance after a DMEK graft partially folded over on itself in a non-fuchs pseudophakic eye.
Topics: Acetazolamide; Aged; Benzeneacetamides; Cataract Extraction; Cornea; Corneal Edema; Descemet Strippi | 2014 |
Significant macular edema in a patient with cone dystrophy and improvement with acetazolamide treatment.
Topics: Acetazolamide; Administration, Oral; Aged; Carbonic Anhydrase Inhibitors; Humans; Macular Edema; Mal | 2014 |
Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Cohort Studies; Delayed-A | 2015 |
[Uveitic macular edema and the pharmacotherapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; | 2015 |
Acetazolamide therapy in a case of fingolimod-associated macular edema: early benefits and long-term limitations.
Topics: Acetazolamide; Administration, Oral; Female; Fingolimod Hydrochloride; Fluorescein Angiography; Foll | 2015 |
Incidence and Characteristics of Cystoid Macular Edema after Cataract Surgery.
Topics: Acetazolamide; Adult; Aged; Aged, 80 and over; Carbonic Anhydrase Inhibitors; Drug Prescriptions; Fe | 2016 |
Macular cystoid spaces in patients with retinal dystrophy.
Topics: Acetazolamide; Administration, Oral; Administration, Topical; Adolescent; Adult; Carbonic Anhydrase | 2016 |
Diagnostic and Therapeutic Challenges.
Topics: Acetazolamide; Administration, Oral; Adult; Diagnosis, Differential; Diuretics; Drug Therapy, Combin | 2016 |
Subtenon triamcinolone for cystoid macular edema due to retinitis pigmentosa unresponsive to oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Eye Proteins; Glucocortic | 2016 |
Carbonic Anhydrase Inhibitors for the Treatment of Cystic Macular Lesions in Children With X-Linked Juvenile Retinoschisis.
Topics: Acetazolamide; Adolescent; Carbonic Anhydrase Inhibitors; Child; Dose-Response Relationship, Drug; F | 2016 |
USE OF A CARBONIC ANHYDRASE INHIBITOR IN X-LINKED RETINOSCHISIS: Effect on Cystic-Appearing Macular Lesions and Visual Acuity.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Child, Preschool; Dose-Respo | 2017 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; B | 2009 |
Unilateral macular oedema in Zermatt and Stargardt macular dystrophies.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Diagnostic Techniques, Ophthalmological; Female | 2009 |
[A case report of two patients with pseudophakia-associated macular edema: can OCT replace fluorescein angiography?].
Topics: Acetazolamide; Aged; Carbonic Anhydrase Inhibitors; Fluorescein Angiography; Humans; Macular Edema; | 2009 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Adult; Electroretinography; Fluorescein Angiography; Fundus Oculi; Humans; Macular Ed | 2011 |
The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis.
Topics: Acetazolamide; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Humans; Macular Edema; Male; Reti | 2011 |
Early serous macular detachment after phacoemulsification surgery.
Topics: Acetazolamide; Cefuroxime; Female; Fluorescein Angiography; Humans; Macular Edema; Male; Middle Aged | 2010 |
Early macular thickening versus pseudophakic cystoid macular edema.
Topics: Acetazolamide; Cefuroxime; Fluorescein Angiography; Humans; Macular Edema; Phacoemulsification; Post | 2011 |
Regression of paclitaxel-induced maculopathy with oral acetazolamide.
Topics: Acetazolamide; Administration, Oral; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chem | 2012 |
[Analysis of prognostic factors by spectral-domain optical coherence tomography in pseudophakic cystoid macular oedema].
Topics: Acetazolamide; Aged; Anti-Inflammatory Agents; Diclofenac; Female; Humans; Macular Edema; Male; Post | 2012 |
Treatment of cystoid macular edema with oral acetazolamide in a patient with best vitelliform macular dystrophy.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angio | 2004 |
Acitretin-associated maculopathy.
Topics: Acetazolamide; Acitretin; Adult; Diuretics; Fluorescein Angiography; Humans; Keratolytic Agents; Mac | 2004 |
[Cystoid macular edema in uveitis].
Topics: Acetazolamide; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Blood-Retinal Barri | 2005 |
[Advantages of acetazolamide associated with anti-inflammatory medications in postoperative treatment of macular edema].
Topics: Acetazolamide; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Drug Therapy, Combination; Fe | 2005 |
Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
Topics: Acetazolamide; Adult; Aged; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angiography; Follow-U | 2006 |
Acetazolamide in the treatment of X-linked retinoschisis maculopathy.
Topics: Acetazolamide; Administration, Oral; Carbonic Anhydrase Inhibitors; Child; Humans; Macular Edema; Ma | 2007 |
Tomographic assessment of therapeutic response to uveitic macular oedema.
Topics: Acetazolamide; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 2007 |
Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angio | 2007 |
Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa.
Topics: Acetazolamide; Administration, Oral; Adult; Aptamers, Nucleotide; Carbonic Anhydrase Inhibitors; Dru | 2009 |
Hyperbaric oxygen and acetazolamide improve visual acuity in patients with cystoid macular edema by different mechanisms.
Topics: Acetazolamide; Combined Modality Therapy; Female; Fluorescein Angiography; Fundus Oculi; Humans; Hyp | 1993 |
Acetazolamide in dominant cystoid macular dystrophy. A pilot study.
Topics: Acetazolamide; Administration, Oral; Adult; Female; Fundus Oculi; Humans; Macular Degeneration; Macu | 1993 |
[Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)].
Topics: Acetazolamide; Adult; Aged; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Admi | 1993 |
Cystoid macular oedema in chronic myeloid leukaemia: treatment with acetazolamide and response to bone marrow transplantation.
Topics: Acetazolamide; Bone Marrow Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1996 |
Acetazolamide treatment of CME in patients with uveitis.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Humans; Macular Edema; Randomized Con | 1996 |
Acetazolamide treatment of CME in patients with uveitis.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Chronic Disease; Humans; Macular Edema; Randomized Con | 1996 |
Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Topics: Acetazolamide; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents, Non-Steroidal | 1998 |
[Treatment of cystoid macular edema].
Topics: Acetazolamide; Anti-Inflammatory Agents; Humans; Lens Implantation, Intraocular; Macular Edema; Post | 1998 |
Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume.
Topics: Acetazolamide; Animals; Basement Membrane; Benzolamide; Carbonic Anhydrase Inhibitors; Carbonic Anhy | 1999 |
Treatment of uveitic macular edema with acetazolamide.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Drug Therapy, Combination; F | 1999 |
True exfoliation of the lens capsule following uveitis.
Topics: Acetazolamide; Aged; Betamethasone; Drug Therapy, Combination; Exfoliation Syndrome; Female; Humans; | 2000 |
Adjunctive hyperbaric oxygenation in macular edema of vascular origin.
Topics: Acetazolamide; Aged; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diuretics; Emergencies; F | 2000 |
Comparison of optical coherence tomography and fluorescein angiography in assessing macular edema in retinal dystrophies: preliminary results.
Topics: Acetazolamide; Administration, Oral; Adult; Carbonic Anhydrase Inhibitors; Female; Fluorescein Angio | 2001 |
Cystoid macular edema after scleral buckling responsive to acetazolamide.
Topics: Acetazolamide; Cell Membrane; Fundus Oculi; Humans; Macular Edema; Male; Middle Aged; Postoperative | 1992 |
Treatment of cystoid macular edema with acetazolamide in a patient with serpiginous choroidopathy.
Topics: Acetazolamide; Choroid Diseases; Fluorescein Angiography; Fundus Oculi; Humans; Macular Edema; Male; | 1991 |
A direct correlation of the resolution of pseudophakic cystoid macular edema with acetazolamide therapy.
Topics: Acetazolamide; Administration, Oral; Aged; Cataract Extraction; Fluorescein Angiography; Fundus Ocul | 1991 |
Treatment of chronic macular oedema with low dosage acetazolamide.
Topics: Acetazolamide; Aged; Chronic Disease; Female; Humans; Macular Edema; Male; Middle Aged | 1990 |
Long-term effect of acetazolamide in a patient with retinitis pigmentosa.
Topics: Acetazolamide; Female; Humans; Longitudinal Studies; Macular Edema; Middle Aged; Psychophysics; Reti | 1990 |
Treatment of chronic macular edema with acetazolamide.
Topics: Acetazolamide; Chronic Disease; Dose-Response Relationship, Drug; Eye Diseases; Fluorescein Angiogra | 1988 |